February 19, 2019 / 4:26 PM / a year ago

U.S. top court rejects bid to block Indivior opioid drug copycat

WASHINGTON, Feb 19 (Reuters) - The U.S. Supreme Court dealt a blow to Indivior Plc on Tuesday, clearing the way for a copycat version of the British pharmaceutical firm’s lucrative opioid addiction treatment Suboxone Film in a victory for India-based generic drug maker Dr. Reddy’s Laboratories .

Chief Justice John Roberts, in a brief order, denied Indivior’s request to put on hold a lower court’s ruling that opened the door to cheaper generic versions of Suboxone while the company prepares an appeal to the high court.

Reporting by Andrew Chung; Editing by Will Dunham

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below